LATE-NC risk alleles (in TMEM106B, GRN , and ABCC9 genes) among persons with African ancestry
Journal of Neuropathology & Experimental Neurology · 21.08.2023 · 82 (9) · 760-768
DOI: 10.1093/jnen/nlad059 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Neuropathology & Experimental Neurology, online erschienen am 01.08.2023. Verfasst von Yuriko Katsumata und 4 weiteren Autor:innen. Beteiligte Einrichtung: University of Kentucky Sanders-Brown Center on Aging, Lexington, Kentucky, USA. Hauptthemen laut MEDLINE: TDP-43 Proteinopathies, Alzheimer Disease. Die Arbeit wurde bisher 22-mal zitiert (Crossref) und nennt 52 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: NIA NIH HHS, NIMH NIH HHS, NHGRI NIH HHS.
Abstract (Originalsprache)
Limbic-predominant age-related TDP-43 encephalopathy (LATE) affects approximately one-third of older individuals and is associated with cognitive impairment. However, there is a highly incomplete understanding of the genetic determinants of LATE neuropathologic changes (LATE-NC) in diverse populations. The defining neuropathologic feature of LATE-NC is TDP-43 proteinopathy, often with comorbid hippocampal sclerosis (HS). In terms of genetic risk factors, LATE-NC and/or HS are associated with single nucleotide variants (SNVs) in 3 genes—TMEM106B (rs1990622), GRN (rs5848), and ABCC9 (rs1914361 and rs701478). We evaluated these 3 genes in convenience samples of individuals of African ancestry. The allele frequencies of the LATE-associated alleles were significantly different between persons of primarily African (versus European) ancestry: In persons of African ancestry, the risk-associated alleles for TMEM106B and ABCC9 were less frequent, whereas the risk allele in GRN was more frequent. We performed an exploratory analysis of data from African-American subjects processed by the Alzheimer’s Disease Genomics Consortium, with a subset of African-American participants (n = 166) having corroborating neuropathologic data through the National Alzheimer’s Coordinating Center (NACC). In this limited-size sample, the ABCC9/rs1914361 SNV was associated with HS pathology. More work is required concerning the genetic factors influencing non-Alzheimer disease pathology such as LATE-NC in diverse cohorts.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- University of Kentucky Sanders-Brown Center on Aging, Lexington, Kentucky, USA.
- University of Kentucky Department of Biostatistics, Lexington, Kentucky, USA.
- University of Kentucky Department of Pathology and Laboratory Medicine, Lexington, Kentucky, USA.
ORCID-Profile: Peter T Nelson
Förderung
- NIA NIH HHS
- NIMH NIH HHS
- NHGRI NIH HHS
- NCRR NIH HHS
- NIMHD NIH HHS
- NINDS NIH HHS
- Howard Hughes Medical Institute
- Medical Research Council
Zitieren
APA
Katsumata, Y., Fardo, D. W., Shade, L. M. P., Alzheimer’s Disease Genetics Consortium, & Nelson, P. T. (2023). LATE-NC risk alleles (in TMEM106B, GRN , and ABCC9 genes) among persons with African ancestry. Journal of Neuropathology & Experimental Neurology, 82(9), 760-768. https://doi.org/10.1093/jnen/nlad059
Vancouver
Katsumata Y, Fardo DW, Shade LMP, Alzheimer’s Disease Genetics Consortium, Nelson PT. LATE-NC risk alleles (in TMEM106B, GRN , and ABCC9 genes) among persons with African ancestry. Journal of Neuropathology & Experimental Neurology. 2023;82(9):760-768. doi:10.1093/jnen/nlad059
BibTeX
@article{Katsumata2023,
author = {Katsumata, Yuriko and Fardo, David W and Shade, Lincoln M P and Alzheimer’s Disease Genetics Consortium, Alzheimer’s Disease Genetics Consortium and Nelson, Peter T},
title = {LATE-NC risk alleles (in TMEM106B, GRN , and ABCC9 genes) among persons with African ancestry},
journal = {Journal of Neuropathology & Experimental Neurology},
year = {2023},
volume = {82},
number = {9},
pages = {760--768},
doi = {10.1093/jnen/nlad059}
}
EUVIMED